SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis.

Tomonori Sasahira, Miyako Kurihara-Shimomura, Hiroyuki Shimomura, Tadaaki Kirita

International journal of clinical oncology 2021 Oct

filter terms:

LEM domain containing 1 (LEMD1) is a novel factor involved in the development of oral squamous cell carcinoma (OSCC). We previously performed a microarray analysis and found that serpin peptidase inhibitor, clade E, member 2 (SERPINE2) is an LEMD1-related signal. SERPINE2 is an extracellular serine proteinase inhibitor with secretory capacity. Although SERPINE2 displays tumor-promoting properties in many cancers, some reports indicate that SRPINE2 also has a tumor-suppressing function. Therefore, there are many unclear points about its role in cancer. In this study, we investigated SERPINE2 expression in OSCC. The gene expression and secretion levels of SERPINE2 were examined in 42 frozen specimens of OSCC, and SERPINE2 immunostaining was investigated in 167 cases of OSCC. Furthermore, the effect of SERPINE2 on angi ogenesis and lymphangiogenesis was analyzed using OSCC cells and endothelial cells. In the frozen specimens, the gene expression (P < 0.0001) and secretion levels (P < 0.0001) of SERPINE2 were higher in OSCC than in the normal oral mucosa. According to the immunohistochemical analysis, SERPINE2 expression was correlated with the depth of invasion (P = 0.0163), nodal metastasis (P = 0.0085), microvessel density (P < 0.0001), and lymphovessel density (P < 0.0001). Additionally, univariate and multivariate analyses indicated that the SERPINE2 expression level was an independent poor prognostic factor for OSCC. In vitro studies using OSCC cells revealed that SERPINE2 promotes angiogenesis and lymphangiogenesis. These results suggest that SRPX2 might be a useful tumor marker for OSCC. © 2021. Japan Society of Clinical Oncology.

Citation

Tomonori Sasahira, Miyako Kurihara-Shimomura, Hiroyuki Shimomura, Tadaaki Kirita. SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis. International journal of clinical oncology. 2021 Oct;26(10):1831-1839